Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide in Cardiac Surgery (CPG-DZX)
NCT06308107Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of diazoxide in Myocardial stunning, sponsored by Johns Hopkins University. Primary endpoints: Mean Arterial Blood Pressure, Blood Glucose Levels and 1 more. Started Jul 2024; status: completed.
02
Drugs
diazoxide
03
Conditions
Myocardial stunning
Beyond the preview
Go deeper on NCT06308107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06308107.